Cargando…
Leukoreduction and hydroxyurea in malignant pertussis: A case series
We report five cases of malignant pertussis, a rare but life‐threatening illness. Current therapies include supportive care and leukoreduction. Notably, leukoreduction might be more effective when initiated prior to the development of organ failure and pulmonary hypertension.
Autores principales: | Aldairi, Nedaa, Alali, Hamza, Kazzaz, Yasser |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7752367/ https://www.ncbi.nlm.nih.gov/pubmed/33363809 http://dx.doi.org/10.1002/ccr3.3264 |
Ejemplares similares
-
Is there justification for universal leukoreduction?
por: Mendrone, Alfredo, et al.
Publicado: (2014) -
Leukemoid Reaction in Infant Pertussis: Is There a Place for Hydroxyurea? A Case Report
por: Maitre, Guillaume, et al.
Publicado: (2018) -
Enhancing teamwork communication and patient safety responsiveness in a paediatric intensive care unit using the daily safety huddle tool
por: Aldawood, Fatima, et al.
Publicado: (2020) -
To filter blood or universal leukoreduction: what is the answer?
por: Shapiro, Marc J
Publicado: (2004) -
Transfusion of pathogen‐reduced platelet components without leukoreduction
por: Sim, Joycelyn, et al.
Publicado: (2019)